Viewing Study NCT02726568


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2025-12-24 @ 5:40 PM
Study NCT ID: NCT02726568
Status: UNKNOWN
Last Update Posted: 2019-02-19
First Post: 2016-03-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module